175 related articles for article (PubMed ID: 18616956)
1. The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats.
de Novellis V; Palazzo E; Rossi F; De Petrocellis L; Petrosino S; Guida F; Luongo L; Migliozzi A; Cristino L; Marabese I; Starowicz K; Di Marzo V; Maione S;
Neuropharmacology; 2008 Dec; 55(7):1105-13. PubMed ID: 18616956
[TBL] [Abstract][Full Text] [Related]
2. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla.
Suplita RL; Farthing JN; Gutierrez T; Hohmann AG
Neuropharmacology; 2005 Dec; 49(8):1201-9. PubMed ID: 16129456
[TBL] [Abstract][Full Text] [Related]
4. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
5. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
[TBL] [Abstract][Full Text] [Related]
6. N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus.
Gobira PH; Lima IV; Batista LA; de Oliveira AC; Resstel LB; Wotjak CT; Aguiar DC; Moreira FA
J Psychopharmacol; 2017 Jun; 31(6):750-756. PubMed ID: 28583049
[TBL] [Abstract][Full Text] [Related]
7. The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice.
Costa B; Bettoni I; Petrosino S; Comelli F; Giagnoni G; Di Marzo V
Pharmacol Res; 2010 Jun; 61(6):537-46. PubMed ID: 20138997
[TBL] [Abstract][Full Text] [Related]
8. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.
Maione S; Costa B; Piscitelli F; Morera E; De Chiaro M; Comelli F; Boccella S; Guida F; Verde R; Ortar G; Di Marzo V
Pharmacol Res; 2013 Oct; 76():98-105. PubMed ID: 23911581
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant effects of N-arachidonoyl-serotonin, a dual fatty acid amide hydrolase enzyme and transient receptor potential vanilloid type-1 (TRPV1) channel blocker, on experimental seizures: the roles of cannabinoid CB1 receptors and TRPV1 channels.
Vilela LR; Medeiros DC; de Oliveira AC; Moraes MF; Moreira FA
Basic Clin Pharmacol Toxicol; 2014 Oct; 115(4):330-4. PubMed ID: 24674273
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
[TBL] [Abstract][Full Text] [Related]
11. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
[TBL] [Abstract][Full Text] [Related]
12. Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT).
Bashashati M; Fichna J; Piscitelli F; Capasso R; Izzo AA; Sibaev A; Timmermans JP; Cenac N; Vergnolle N; Di Marzo V; Storr M
Neurogastroenterol Motil; 2017 Dec; 29(12):. PubMed ID: 28695708
[TBL] [Abstract][Full Text] [Related]
13. The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats.
de Novellis V; Vita D; Gatta L; Luongo L; Bellini G; De Chiaro M; Marabese I; Siniscalco D; Boccella S; Piscitelli F; Di Marzo V; Palazzo E; Rossi F; Maione S
Mol Pain; 2011 Jan; 7():7. PubMed ID: 21241462
[TBL] [Abstract][Full Text] [Related]
14. Functional interaction between TRPV1 and mu-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesia.
Maione S; Starowicz K; Cristino L; Guida F; Palazzo E; Luongo L; Rossi F; Marabese I; de Novellis V; Di Marzo V
J Neurophysiol; 2009 May; 101(5):2411-22. PubMed ID: 19297510
[TBL] [Abstract][Full Text] [Related]
15. Effects of intra-ventrolateral periaqueductal grey palmitoylethanolamide on thermoceptive threshold and rostral ventromedial medulla cell activity.
de Novellis V; Luongo L; Guida F; Cristino L; Palazzo E; Russo R; Marabese I; D'Agostino G; Calignano A; Rossi F; Di Marzo V; Maione S
Eur J Pharmacol; 2012 Feb; 676(1-3):41-50. PubMed ID: 22178921
[TBL] [Abstract][Full Text] [Related]
16. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat.
de Novellis V; Mariani L; Palazzo E; Vita D; Marabese I; Scafuro M; Rossi F; Maione S
Neuroscience; 2005; 134(1):269-81. PubMed ID: 15953687
[TBL] [Abstract][Full Text] [Related]
17. Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways.
Starowicz K; Maione S; Cristino L; Palazzo E; Marabese I; Rossi F; de Novellis V; Di Marzo V
J Neurosci; 2007 Dec; 27(50):13739-49. PubMed ID: 18077685
[TBL] [Abstract][Full Text] [Related]
18. New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain.
Ortar G; Cascio MG; De Petrocellis L; Morera E; Rossi F; Schiano-Moriello A; Nalli M; de Novellis V; Woodward DF; Maione S; Di Marzo V
J Med Chem; 2007 Dec; 50(26):6554-69. PubMed ID: 18027904
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats.
Pardo-García TR; Yusif-Rodriguez N; Yudowski G; Maldonado-Vlaar CS
Neurosci Lett; 2020 Jul; 732():135023. PubMed ID: 32422166
[TBL] [Abstract][Full Text] [Related]
20. Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy.
Silva M; Martins D; Charrua A; Piscitelli F; Tavares I; Morgado C; Di Marzo V
Neuropharmacology; 2016 Aug; 107():49-57. PubMed ID: 26965218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]